Potential conflict of interest: Dr. Hamzeh is an employee of Genentech. Dr. Hoop owns stock in Genentech. Dr. Terrault consults for and received grants from Genentech and Gilead. She consults for Merck, Siemens, and Vertex. She also received grants from Novartis and Bristol-Myers Squibb.
Version of Record online: 9 OCT 2012
Copyright © 2012 American Association for the Study of Liver Diseases
Volume 56, Issue 5, pages 1651–1660, November 2012
How to Cite
Gordon, S. C., Pockros, P. J., Terrault, N. A., Hoop, R. S., Buikema, A., Nerenz, D. and Hamzeh, F. M. (2012), Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection. Hepatology, 56: 1651–1660. doi: 10.1002/hep.25842
Supported by a grant from Genentech.
- Issue online: 31 OCT 2012
- Version of Record online: 9 OCT 2012
- Accepted manuscript online: 18 MAY 2012 11:48AM EST
- Manuscript Accepted: 7 MAY 2012
- Manuscript Received: 16 DEC 2011
Vol. 58, Issue 3, 1193, Version of Record online: 1 AUG 2013
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.